A Phase 3 Open-label, Randomized, Controlled Study to Evaluate the Efficacy and Safety of Intravenously Administered Ravulizumab Compared with Best Supportive Care in Patients with COVID-19 Severe Pneumonia, Acute Lung Injury, or Acute Respiratory Distress Syndrome: A structured summary of a study protocol for a randomised controlled trial.

ABSTRACT:

SUBMITTER: Smith K 

PROVIDER: S-EPMC7355517 | biostudies-literature | 2020 Jul

REPOSITORIES: biostudies-literature